ss-31 peptide elamipretide rapidly improves physiological and mitochondrial function in aging

Isabella Young logo
Isabella Young

ss-31 peptide elamipretide SS-31, a mitochondria-targeting antioxidant - SS-31 peptidefor sale SS-31 targets mitochondria Understanding the SS-31 Peptide Elamipretide: A Deep Dive into Mitochondrial Health

SS-31 peptidedosage The SS-31 peptide elamipretide, also known by its development codes SS-31, MTP-131, and brand name FORZINITY™, has emerged as a significant therapeutic agent with a primary focus on improving mitochondrial function. This mitochondria-targeted peptide is a synthetic tetrapeptide composed of D-Arg-Dmt-Lys-Phe-NH2. Its unique structure allows it to selectively accumulate within the inner mitochondrial membrane, where it exerts its beneficial effects. Research indicates that elamipretide is currently being developed by Stealth BioTherapeutics and represents a novel therapeutic approach to address fundamental cellular energetic dysfunction.

The Mechanism of Action: Targeting the Powerhouses of Cells

Mitochondria are often referred to as the "powerhouses of the cell" because they are responsible for generating most of the cell's supply of adenosine triphosphate (ATP), used as a source of chemical energy2025年9月25日—From previously published research, the scientists suspected thatSS-31, a small molecule now known as elamipretidethat interacts with .... Dysfunction in these organelles can lead to a variety of health issues, including aging-related decline and various orphan diseases. SS-31 peptide functions by directly interacting with and stabilizing mitochondrial cristae structure, thereby improving mitochondrial energetics.

One of the key mechanisms by which elamipretide operates is by improving ADP sensitivity in aged mitochondria. This is achieved by increasing the uptake of ADP through the adenine nucleotide transporter. Furthermore, SS-31 acts as a potent mitochondrial antioxidant peptide, effectively eliminating excessive reactive oxygen species (ROS) produced during cellular respiration.Mitochondrialtargeted peptide rapidly improves mitochondrial energetics ... This reduction in oxidative stress helps to restore redox homeostasis and protect cellular components from damageElamipretide(MTP-131,SS-31) is a cytochrome c peroxidase inhibitor.Elamipretideimproves mitochondrial dysfunction, synaptic and memory impairment .... Studies have shown that treatment with SS-31 restores redox homeostasis, improves mitochondrial quality, and increases exercise tolerance without a concurrent increase in mitochondrial contentElamipretide (Brand Name FORZINITY™ for Barth Syndrome).

Therapeutic Applications and Clinical Significance

The therapeutic potential of elamipretide is being explored across a range of conditions characterized by mitochondrial dysfunction.2026年1月24日—SS-31 (Elamipretide) is a targeted mitochondrial peptide that restores ATP production and reduces oxidative stress at the cellular level. Notably, elamipretide is a medication used for the treatment of Barth syndrome, a rare genetic disorder. Beyond this specific indication, elamipretide is being investigated in late-stage clinical studies for mitochondrial diseases such as Barth Syndrome and orphan diseases with cardiomyopathy.

The impact of SS-31 extends to age-related declineSS-31 Peptide | Cellular Energy & Repair. Research suggests that elamipretide (SS-31) rapidly improves physiological and mitochondrial function in aging. In animal models, late-life restoration of mitochondrial function with the mitochondrial targeted peptide SS-31 (elamipretide) can substantially reverse age-related deficits. Moreover, SS-31 improves cognitive functions by promoting mitochondrial and synaptic health and decreasing neuroinflammation, indicating its potential in neurodegenerative conditions.

Elamipretide: A Multifaceted Therapeutic

Beyond its primary role in mitochondrial health, elamipretide (SS-31) demonstrates a broader range of beneficial effects. It has been observed to improve mitochondrial dysfunction, synaptic and memory impairment. The SS-31 peptide's ability to target mitochondria and boost ATP production, reduce oxidative stress, and support cellular recovery positions it as a promising therapeutic agent.

The chemical structure of SS-31(D-Arg-Dmt-Lys-Phe-NH2), with its alternating cationic and aromatic residues, contributes to its membrane-binding properties2025年10月10日—Elamipretide, originally known as SS-31,is a mitochondrially targeted small moleculeoriginally thought to be an antioxidant akin to .... This interaction with lipid bilayers and modulation of surface electrostatics are key components of its mechanism of action. The SS-31 peptide represents a novel therapeutic strategy that goes beyond simple antioxidant effects, as it was originally thought to be, and instead targets the fundamental energetic processes within cells.

In summary, the SS-31 peptide elamipretide is a groundbreaking mitochondria-targeting peptide with demonstrated efficacy in improving mitochondrial function, reducing oxidative stress, and enhancing cellular energy productionOriginally developed as a mitochondria-penetrating peptide,SS-31 represents a novel therapeutic approachaddressing fundamental cellular energetic dysfunction .... Its application in treating specific rare diseases like Barth Syndrome, coupled with its potential to combat age-related decline and neurological impairment, underscores its significant promise in modern medicine.SS-31 (also known as Elamipretide®, Bendavia®, and ...

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.